Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Jairo M. González-Díaz"'
Autor:
Ana M. Sánchez-Torres, Silvia Amoretti, Mónica Enguita-Germán, Gisela Mezquida, Lucía Moreno-Izco, Rocío Panadero-Gómez, Lide Rementería, Alba Toll, Roberto Rodriguez-Jimenez, Alexandra Roldán, Edith Pomarol-Clotet, Ángela Ibáñez, Judith Usall, Fernando Contreras, Eduard Vieta, Jose M. López-Ilundain, Jessica Merchán-Naranjo, Ana González-Pinto, Esther Berrocoso, Miguel Bernardo, Manuel J. Cuesta, María Florencia Forte, Jairo M. González-Díaz, Mara Parellada, Hayford Abrokwa, María Sans Segura, Judit Selma González, Iñaki Zorrilla, Itxaso González-Ortega, Teresa Legido, Anna Mané, Luis Sanchez-Pastor, David Rentero, Salvador Sarró, Maria Ángeles García-León, Anna Butjosa, Marta Pardo, Amalia Zarzuela, María Ribeiro, Jerónimo Saiz-Ruiz, Leticia León-Quismondo, Miguel Hernández, Concepción de la Cámara, Miguel Gutiérrez-Fraile, Leticia González-Blanco
Publikováno v:
European Neuropsychopharmacology. 67:53-65
Schizophrenia is frequently characterized by the presence of multiple relapses. Cognitive impairments are core features of schizophrenia. Cognitive reserve (CR) is the ability of the brain to compensate for damage caused by pathologies such as psycho
Autor:
Cindy N. Noguera Novoa, Yorcelis T. Sarmiento-Melendez, Gloria M. Sierra-Hincapié, Jairo M. González-Díaz
Publikováno v:
Revista Colombiana de Psiquiatría.
Autor:
Cristina Saiz-Masvidal, Fernando Contreras, Carles Soriano-Mas, Gisela Mezquida, Covadonga M. Díaz-Caneja, Eduard Vieta, Silvia Amoretti, Antonio Lobo, Ana González-Pinto, Joost Janssen, Maria Sagué-Vilavella, Josefina Castro-Fornieles, Daniel Bergé, Miquel Bioque, Noemi G. Lois, Mara Parellada, Miguel Bernardo, Clemente García-Rizo, Jairo M. González-Díaz, Laura Pina-Camacho, Elisa Rodríguez-Toscano, Iñaki Zorrilla, Purificación Lopez-Pena, Concepción De-la-Cámara, Pedro Modrego-Pardo, Mª. Jose Escartí, Juan Nacher, Guillermo Vázquez, Sílvia Cristeto, Isabel Valli, Carla Torrent, Imma Baeza, Elena de la Serna, J.M. Menchón, Ignacio Martínez-Zalacaín, Pilar A. Sáiz, Leticia González-Blanco, Roberto Rodriguez-Jimenez, Luis Sanchez-Pastor, Judith Usall, Anna Butjosa, Edith Pomarol-Clotet, Raymond Salvador
Publikováno v:
Progress in neuro-psychopharmacologybiological psychiatry. 120
The relationship between structural brain alterations and prediction of clinical improvement in first-episode psychosis (FEP) has been scarcely studied. We investigated whether structural covariance, a well-established approach to identify abnormal p
Publikováno v:
Revista Colombiana de Psiquiatría (English ed.). 51:2-3
Publikováno v:
Guía de decisión en urgencias medicina del adulto (GUMA)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3eec651b1330a95141cc324399800ed
https://doi.org/10.2307/j.ctvb4bt22.12
https://doi.org/10.2307/j.ctvb4bt22.12
Publikováno v:
Reszka SS, Boyd BA, McBee M, Hume KA, Odom SL. Brief report: concurrent validity of autism symptom severity measures. J Autism Dev Disord. Springer; 2014;44(2):466–70.
Nazeer A, Ghaziuddin M. Autism spectrum disorders: clinical features and diagnosis. Pediatr Clin North Am. Elsevier; 2012;59(1):19–25.
Lee YJ, Oh SH, Park C, Hong M, Lee AR, Yoo HJ, et al. Advanced pharmacotherapy evidenced by pathogenesis of autism spectrum disorder. Clin Psychopharmacol Neurosci. Korea (South); 2014 Apr;12(1):19–30.
Aman MG, Lam KSL, Collier-Crespin A. Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio. J Autism Dev Disord. United States; 2003 Oct;33(5):527–34.
Kotagal S, Broomall E. Sleep in children with autism spectrum disorder. Pediatr Neurol. Elsevier; 2012;47(4):242–51.
Melke J. The role of melatonin in autism spectrum disorders. Scand Neuropsychopharmacol. 2009;2(1).
Tordjman S, Najjar I, Bellissant E, Anderson GM, Barburoth M, Cohen D, et al. Advances in the research of melatonin in autism spectrum disorders: literature review and new perspectives. Int J Mol Sci. Multidisciplinary Digital Publishing Institute; 2013;14(10):20508–42.
Centers for Disease Control and Prevention. Autism Spectrum Disorder (ASD) [Internet]. 2015 [cited 2015 Oct 10]. Available from: http://www.cdc.gov/ncbddd/autism/data.html
Allik H, Larsson J-O, Smedje H. Sleep patterns in school-age children with Asperger syndrome or high-functioning autism: a follow-up study. J Autism Dev Disord. United States; 2008 Oct;38(9):1625–33.
Giannotti F, Cortesi F, Cerquiglini A, Miraglia D, Vagnoni C, Sebastiani T, et al. An investigation of sleep characteristics, EEG abnormalities and epilepsy in developmentally regressed and non-regressed children with autism. J Autism Dev Disord. United States; 2008 Nov;38(10):1888–97
Liu X, Hubbard JA, Fabes RA, Adam JB. Sleep disturbances and correlates of children with autism spectrum disorders. Child Psychiatry Hum Dev. United States; 2006;37(2):179–91.
Barnevik Olsson M, Carlsson LH, Westerlund J, Gillberg C, Fernell E. Autism before diagnosis: crying, feeding and sleeping problems in the first two years of life. Acta Paediatr. Norway; 2013 Jun;102(6):635–9.
Mayes SD, Calhoun SL. Variables related to sleep problems in children with autism. Res Autism Spectr Disord. Elsevier; 2009;3(4):931–41.
Miano S, Bruni O, Elia M, Trovato A, Smerieri A, Verrillo E, et al. Sleep in children with autistic spectrum disorder: a questionnaire and polysomnographic study. Sleep Med. Netherlands; 2007 Dec;9(1):64–70.
Hodge D, Carollo TM, Lewin M, Hoffman CD, Sweeney DP. Sleep patterns in children with and without autism spectrum disorders: developmental comparisons. Res Dev Disabil. United States; 2014 Jul;35(7):1631–8.
Goldman SE, Richdale AL, Clemons T, Malow BA. Parental sleep concerns in autism spectrum disorders: variations from childhood to adolescence. J Autism Dev Disord. United States; 2012 Apr;42(4):531–8.
Malow BA, Byars K, Johnson K, Weiss S, Bernal P, Goldman SE, et al. A practice pathway for the identification, evaluation, and management of insomnia in children and adolescents with autism spectrum disorders. Pediatrics. United States; 2012 Nov;130 Suppl :S106–24.
Goldman SE, McGrew S, Johnson KP, Richdale AL, Clemons T, Malow BA. Sleep is associated with problem behaviors in children and adolescents with autism spectrum disorders. Res Autism Spectr Disord. Elsevier; 2011;5(3):1223–9.
DeVincent CJ, Gadow KD, Delosh D, Geller L. Sleep disturbance and its relation to DSM-IV psychiatric symptoms in preschool-age children with pervasive developmental disorder and community controls. J Child Neurol. Canada; 2007 Feb;22(2):161–9.
Sikora DM, Johnson K, Clemons T, Katz T. The relationship between sleep problems and daytime behavior in children of different ages with autism spectrum disorders. Pediatrics. United States; 2012 Nov;130 Suppl :S83–90.
Patzold LM, Richdale AL, Tonge BJ. An investigation into sleep characteristics of children with autism and Asperger’s Disorder. J Paediatr Child Health. AUSTRALIA; 1998 Dec;34(6):528– 33.
Hodge D, Hoffman CD, Sweeney DP, Riggs ML. Relationship between children’s sleep and mental health in mothers of children with and without autism. J Autism Dev Disord. United States; 2013 Apr;43(4):956–63.
Vriend JL, Corkum P V, Moon EC, Smith IM. Behavioral interventions for sleep problems in children with autism spectrum disorders: current findings and future directions. J Pediatr Psychol. United States; 2011 Oct;36(9):1017–29.
Rossignol DA, Frye RE. Melatonin in autism spectrum disorders: a systematic review and metaanalysis. Dev Med Child Neurol. England; 2011 Sep;53(9):783–92.
Kanner L. Autistic disturbances of affective contact. Nerv Child. 1943
Asperger H. Die „Autistischen Psychopathen” im Kindesalter. Eur Arch Psychiatry Clin Neurosci. Springer; 1944;117(1):76–136.
Wing L. Asperger’s syndrome: a clinical account. Psychol Med. Cambridge Univ Press; 1981;11(01):115–29.
Rutter M. Diagnosis and definition of childhood autism. J Autism Child Schizophr. Springer; 1978;8(2):139–61.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. American Psychiatric Publishing; 2013.
Fombonne E. Epidemiology of pervasive developmental disorders. Pediatr Res. Nature Publishing Group; 2009;65(6):591–8.
Duchan E, Patel DR. Epidemiology of autism spectrum disorders. Pediatr Clin North Am. Elsevier; 2012;59(1):27–43.
Fisch GS. Nosology and epidemiology in autism: classification counts. Am J Med Genet C Semin Med Genet. United States; 2012 May;160C(2):91–103.
Elsabbagh M, Divan G, Koh Y-J, Kim YS, Kauchali S, Marcin C, et al. Global prevalence of autism and other pervasive developmental disorders. Autism Res. United States; 2012 Jun;5(3):160–79.
Hultman CM, Sandin S, Levine SZ, Lichtenstein P, Reichenberg A. Advancing paternal age and risk of autism: new evidence from a population-based study and a meta-analysis of epidemiological studies. Mol Psychiatry. England; 2011 Dec;16(12):1203–12.
Kong A, Frigge ML, Masson G, Besenbacher S, Sulem P, Magnusson G, et al. Rate of de novo mutations and the importance of father’s age to disease risk. Nature. England; 2012
Gardener H, Spiegelman D, Buka SL. Prenatal risk factors for autism: comprehensive metaanalysis. Br J Psychiatry. England; 2009 Jul;195(1):7–14.
Roberts EM, English PB, Grether JK, Windham GC, Somberg L, Wolff C. Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley. Environ Health Perspect. United States; 2007 Oct;115(10):1482–9.
Howlin P, Moss P, Savage S, Rutter M. Social outcomes in mid-to later adulthood among individuals diagnosed with autism and average nonverbal IQ as children. J Am Acad Child Adolesc Psychiatry. United States; 2013 Jun;52(6):572–81.e1.
Johnson CP, Myers SM. Identification and evaluation of children with autism spectrum disorders. Pediatrics. Am Acad Pediatrics; 2007;120(5):1183–215.
Rogers SJ. What are infant siblings teaching us about autism in infancy? Autism Res. United States; 2009 Jun;2(3):125–37.
Via E, Radua J, Cardoner N, Happe F, Mataix-Cols D. Meta-analysis of gray matter abnormalities in autism spectrum disorder: should Asperger disorder be subsumed under a broader umbrella of autistic spectrum disorder? Arch Gen Psychiatry. United States; 2011 Apr;68(4):409–18.
Radua J, Via E, Catani M, Mataix-Cols D. Voxel-based meta-analysis of regional white-matter volume differences in autism spectrum disorder versus healthy controls. Psychol Med. England; 2011 Jul;41(7):1539–50.
Philip RCM, Dauvermann MR, Whalley HC, Baynham K, Lawrie SM, Stanfield AC. A systematic review and meta-analysis of the fMRI investigation of autism spectrum disorders. Neurosci Biobehav Rev. United States; 2012 Feb;36(2):901–42.
Amaral DG, Schumann CM, Nordahl CW. Neuroanatomy of autism. Trends Neurosci. Elsevier; 2008;31(3):137–45.
Pardo CA, Vargas DL, Zimmerman AW. Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry. England; 2005 Dec;17(6):485–95.
Ronald A, Hoekstra RA. Autism spectrum disorders and autistic traits: a decade of new twin studies. Am J Med Genet B Neuropsychiatr Genet. United States; 2011 Apr;156B(3):255–74.
Banerjee S, Riordan M, Bhat MA. Genetic aspects of autism spectrum disorders: insights from animal models. Front Cell Neurosci. Switzerland; 2014;8:58.
Brentani H, Paula CS de, Bordini D, Rolim D, Sato F, Portolese J, et al. Autism spectrum disorders: an overview on diagnosis and treatment. Rev Bras Psiquiatr. Brazil; 2013;35 Suppl 1:S62–72.
Akins RS, Angkustsiri K, Hansen RL. Complementary and alternative medicine in autism: an evidence-based approach to negotiating safe and efficacious interventions with families. Neurotherapeutics. United States; 2010 Jul;7(3):307–19.
Lerner AB, Case JD, Takahashi Y, Lee TH, Mori W. Isolation of melatonin, the pineal gland factor that lightens melanocyteS1. J Am Chem Soc. ACS Publications; 1958;80(10):2587.
Malenka RC, Nestler EJ, Hyman SE, Sydor A, Brown RY. Molecular Neuropharmacology: A Foundation for Clinical Neuroscience. New York: McGrawHill Medical. Book; 2009.
Reiter RJ. The melatonin rhythm: both a clock and a calendar. Experientia. Springer; 1993;49(8):654–64.
Dubocovich ML, Rivera-Bermudez MA, Gerdin MJ, Masana MI. Molecular pharmacology, regulation and function of mammalian melatonin receptors. Front Biosci. United States; 2003 Sep;8:d1093–108
Carocci A, Catalano A, Sinicropi MS. Melatonergic drugs in development. Clin Pharmacol Adv Appl. Dove Press; 2014;6:127.
De Leersnyder H, Zisapel N, Laudon M. Prolonged-release melatonin for children with neurodevelopmental disorders. Pediatr Neurol. Elsevier; 2011;45(1):23–6.
Illnait-Ferrer J. Melatonina: actualidad de una hormona olvidada Melatonin: the actuality of a forgotten hormone. Rev CENIC Ciencias Biológicas. 2012;43(3).
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. Elsevier; 1996;17(1):1–12.
Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Wiley Online Library; 2008.
Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ Br Med J. BMJ Group; 2003;327(7414):557.
Cortesi F, Giannotti F, Sebastiani T, Panunzi S, Valente D. Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: a randomized placebo-controlled trial. J Sleep Res. England; 2012
Garstang J, Wallis M. Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems. Child Care Health Dev. England; 2006 Sep;32(5):585–9.
Wright B, Sims D, Smart S, Alwazeer A, Alderson-Day B, Allgar V, et al. Melatonin versus placebo in children with autism spectrum conditions and severe sleep problems not amenable to behaviour management strategies: a randomised controlled crossover trial. J Autism Dev Disord. United States; 2011 Feb;41(2):175–84.
Levy SE, Mandell DS, Merhar S, Ittenbach RF, Pinto-Martin JA. Use of complementary and alternative medicine among children recently diagnosed with autistic spectrum disorder. J Dev Behav Pediatr. LWW; 2003;24(6):418–23.
Jan JE, Hamilton D, Seward N, Fast DK, Freeman RD, Laudon M. Clinical trials of controlledrelease melatonin in children with sleep-wake cycle disorders. J Pineal Res. New York: Liss, c1984-; 2000;29(1):34–9.
República de Colombia Ministerio de Salud y Protección Social Instituto Nacional de Vigilancia de Medicamentos y Alimentos – INVIMA. RESOLUCIÓN No. 2015013919 DE 13 de Abril de 2015 Por la cual se concede un Registro Sanitario [Internet]. Bogotá: INVIMA; 2015 p. 1–3. Available from: http://web.sivicos.gov.co/registros/pdf/1287670_2015013919.pdf
Neurim Pharmaceuticals. Circadin® 2mg (prolonged-release melatonin) is now commercially available in Colombia [Internet]. 2015 [cited 2016 Oct 16]. Available from: http://www.neurim.com/news/2015-10-01/circadin-2mg-prolonged-release-melatonin-is-nowcommercially-available-in-colombia/
Johnson KP, Malow BA. Assessment and pharmacologic treatment of sleep disturbance in autism. Child Adolesc Psychiatr Clin N Am. Elsevier; 2008;17(4):773–85.
Melke J, Botros HG, Chaste P, Betancur C, Nygren G, Anckarsäter H, et al. Abnormal melatonin synthesis in autism spectrum disorders. Mol Psychiatry. Nature Publishing Group; 2008;13(1):90–8.
Reiter R, Tang L, Garcia JJ, Munoz-Hoyos A. Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci. ENGLAND; 1997;60(25):2255–71.
Chauhan A, Chauhan V. Oxidative stress in autism. Pathophysiology. Elsevier; 2006;13(3):171– 81.
Cohly HHP, Panja A. Immunological findings in autism. Int Rev Neurobiol. Elsevier; 2005;71:317–4
El-Sherif Y, Tesoriero J, Hogan M V, Wieraszko A. Melatonin regulates neuronal plasticity in the hippocampus. J Neurosci Res. United States; 2003 May;72(4):454–60.
Golombek DA, Pevet P, Cardinali DP. Melatonin effects on behavior: possible mediation by the central GABAergic system. Neurosci Biobehav Rev. UNITED STATES; 1996;20(3):403–12.
Niles LP, Pickering DS, Arciszewski MA. Effects of chronic melatonin administration on GABA and diazepam binding in rat brain. J Neural Transm. AUSTRIA; 1987;70(1-2):117–24.
Pandi-Perumal SR, Srinivasan V, Maestroni GJM, Cardinali DP, Poeggeler B, Hardeland R. Melatonin: Nature’s most versatile biological signal? FEBS J. England; 2006 Jul;273(13):2813– 38.
Campino C, Valenzuela FJ, Torres-Farfan C, Reynolds HE, Abarzua-Catalan L, Arteaga E, et al. Melatonin exerts direct inhibitory actions on ACTH responses in the human adrenal gland. Horm Metab Res = Horm und Stoffwechselforsch = Horm Metab. Germany; 2011 May;43(5):337–42.
Malow B, Adkins KW, McGrew SG, Wang L, Goldman SE, Fawkes D, et al. Melatonin for sleep in children with autism: a controlled trial examining dose, tolerability, and outcomes. J Autism Dev Disord. United States; 2012 Aug;42(8):1729–37; author reply 1738.
Jan JE, O’Donnell ME. Use of melatonin in the treatment of paediatric sleep disorders. J Pineal Res. Wiley Online Library; 1996;21(4):193–9
Andersen IM, Kaczmarska J, McGrew SG, Malow BA. Melatonin for insomnia in children with autism spectrum disorders. J Child Neurol. Canada; 2008 May;23(5):482–5.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Nazeer A, Ghaziuddin M. Autism spectrum disorders: clinical features and diagnosis. Pediatr Clin North Am. Elsevier; 2012;59(1):19–25.
Lee YJ, Oh SH, Park C, Hong M, Lee AR, Yoo HJ, et al. Advanced pharmacotherapy evidenced by pathogenesis of autism spectrum disorder. Clin Psychopharmacol Neurosci. Korea (South); 2014 Apr;12(1):19–30.
Aman MG, Lam KSL, Collier-Crespin A. Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio. J Autism Dev Disord. United States; 2003 Oct;33(5):527–34.
Kotagal S, Broomall E. Sleep in children with autism spectrum disorder. Pediatr Neurol. Elsevier; 2012;47(4):242–51.
Melke J. The role of melatonin in autism spectrum disorders. Scand Neuropsychopharmacol. 2009;2(1).
Tordjman S, Najjar I, Bellissant E, Anderson GM, Barburoth M, Cohen D, et al. Advances in the research of melatonin in autism spectrum disorders: literature review and new perspectives. Int J Mol Sci. Multidisciplinary Digital Publishing Institute; 2013;14(10):20508–42.
Centers for Disease Control and Prevention. Autism Spectrum Disorder (ASD) [Internet]. 2015 [cited 2015 Oct 10]. Available from: http://www.cdc.gov/ncbddd/autism/data.html
Allik H, Larsson J-O, Smedje H. Sleep patterns in school-age children with Asperger syndrome or high-functioning autism: a follow-up study. J Autism Dev Disord. United States; 2008 Oct;38(9):1625–33.
Giannotti F, Cortesi F, Cerquiglini A, Miraglia D, Vagnoni C, Sebastiani T, et al. An investigation of sleep characteristics, EEG abnormalities and epilepsy in developmentally regressed and non-regressed children with autism. J Autism Dev Disord. United States; 2008 Nov;38(10):1888–97
Liu X, Hubbard JA, Fabes RA, Adam JB. Sleep disturbances and correlates of children with autism spectrum disorders. Child Psychiatry Hum Dev. United States; 2006;37(2):179–91.
Barnevik Olsson M, Carlsson LH, Westerlund J, Gillberg C, Fernell E. Autism before diagnosis: crying, feeding and sleeping problems in the first two years of life. Acta Paediatr. Norway; 2013 Jun;102(6):635–9.
Mayes SD, Calhoun SL. Variables related to sleep problems in children with autism. Res Autism Spectr Disord. Elsevier; 2009;3(4):931–41.
Miano S, Bruni O, Elia M, Trovato A, Smerieri A, Verrillo E, et al. Sleep in children with autistic spectrum disorder: a questionnaire and polysomnographic study. Sleep Med. Netherlands; 2007 Dec;9(1):64–70.
Hodge D, Carollo TM, Lewin M, Hoffman CD, Sweeney DP. Sleep patterns in children with and without autism spectrum disorders: developmental comparisons. Res Dev Disabil. United States; 2014 Jul;35(7):1631–8.
Goldman SE, Richdale AL, Clemons T, Malow BA. Parental sleep concerns in autism spectrum disorders: variations from childhood to adolescence. J Autism Dev Disord. United States; 2012 Apr;42(4):531–8.
Malow BA, Byars K, Johnson K, Weiss S, Bernal P, Goldman SE, et al. A practice pathway for the identification, evaluation, and management of insomnia in children and adolescents with autism spectrum disorders. Pediatrics. United States; 2012 Nov;130 Suppl :S106–24.
Goldman SE, McGrew S, Johnson KP, Richdale AL, Clemons T, Malow BA. Sleep is associated with problem behaviors in children and adolescents with autism spectrum disorders. Res Autism Spectr Disord. Elsevier; 2011;5(3):1223–9.
DeVincent CJ, Gadow KD, Delosh D, Geller L. Sleep disturbance and its relation to DSM-IV psychiatric symptoms in preschool-age children with pervasive developmental disorder and community controls. J Child Neurol. Canada; 2007 Feb;22(2):161–9.
Sikora DM, Johnson K, Clemons T, Katz T. The relationship between sleep problems and daytime behavior in children of different ages with autism spectrum disorders. Pediatrics. United States; 2012 Nov;130 Suppl :S83–90.
Patzold LM, Richdale AL, Tonge BJ. An investigation into sleep characteristics of children with autism and Asperger’s Disorder. J Paediatr Child Health. AUSTRALIA; 1998 Dec;34(6):528– 33.
Hodge D, Hoffman CD, Sweeney DP, Riggs ML. Relationship between children’s sleep and mental health in mothers of children with and without autism. J Autism Dev Disord. United States; 2013 Apr;43(4):956–63.
Vriend JL, Corkum P V, Moon EC, Smith IM. Behavioral interventions for sleep problems in children with autism spectrum disorders: current findings and future directions. J Pediatr Psychol. United States; 2011 Oct;36(9):1017–29.
Rossignol DA, Frye RE. Melatonin in autism spectrum disorders: a systematic review and metaanalysis. Dev Med Child Neurol. England; 2011 Sep;53(9):783–92.
Kanner L. Autistic disturbances of affective contact. Nerv Child. 1943
Asperger H. Die „Autistischen Psychopathen” im Kindesalter. Eur Arch Psychiatry Clin Neurosci. Springer; 1944;117(1):76–136.
Wing L. Asperger’s syndrome: a clinical account. Psychol Med. Cambridge Univ Press; 1981;11(01):115–29.
Rutter M. Diagnosis and definition of childhood autism. J Autism Child Schizophr. Springer; 1978;8(2):139–61.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. American Psychiatric Publishing; 2013.
Fombonne E. Epidemiology of pervasive developmental disorders. Pediatr Res. Nature Publishing Group; 2009;65(6):591–8.
Duchan E, Patel DR. Epidemiology of autism spectrum disorders. Pediatr Clin North Am. Elsevier; 2012;59(1):27–43.
Fisch GS. Nosology and epidemiology in autism: classification counts. Am J Med Genet C Semin Med Genet. United States; 2012 May;160C(2):91–103.
Elsabbagh M, Divan G, Koh Y-J, Kim YS, Kauchali S, Marcin C, et al. Global prevalence of autism and other pervasive developmental disorders. Autism Res. United States; 2012 Jun;5(3):160–79.
Hultman CM, Sandin S, Levine SZ, Lichtenstein P, Reichenberg A. Advancing paternal age and risk of autism: new evidence from a population-based study and a meta-analysis of epidemiological studies. Mol Psychiatry. England; 2011 Dec;16(12):1203–12.
Kong A, Frigge ML, Masson G, Besenbacher S, Sulem P, Magnusson G, et al. Rate of de novo mutations and the importance of father’s age to disease risk. Nature. England; 2012
Gardener H, Spiegelman D, Buka SL. Prenatal risk factors for autism: comprehensive metaanalysis. Br J Psychiatry. England; 2009 Jul;195(1):7–14.
Roberts EM, English PB, Grether JK, Windham GC, Somberg L, Wolff C. Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley. Environ Health Perspect. United States; 2007 Oct;115(10):1482–9.
Howlin P, Moss P, Savage S, Rutter M. Social outcomes in mid-to later adulthood among individuals diagnosed with autism and average nonverbal IQ as children. J Am Acad Child Adolesc Psychiatry. United States; 2013 Jun;52(6):572–81.e1.
Johnson CP, Myers SM. Identification and evaluation of children with autism spectrum disorders. Pediatrics. Am Acad Pediatrics; 2007;120(5):1183–215.
Rogers SJ. What are infant siblings teaching us about autism in infancy? Autism Res. United States; 2009 Jun;2(3):125–37.
Via E, Radua J, Cardoner N, Happe F, Mataix-Cols D. Meta-analysis of gray matter abnormalities in autism spectrum disorder: should Asperger disorder be subsumed under a broader umbrella of autistic spectrum disorder? Arch Gen Psychiatry. United States; 2011 Apr;68(4):409–18.
Radua J, Via E, Catani M, Mataix-Cols D. Voxel-based meta-analysis of regional white-matter volume differences in autism spectrum disorder versus healthy controls. Psychol Med. England; 2011 Jul;41(7):1539–50.
Philip RCM, Dauvermann MR, Whalley HC, Baynham K, Lawrie SM, Stanfield AC. A systematic review and meta-analysis of the fMRI investigation of autism spectrum disorders. Neurosci Biobehav Rev. United States; 2012 Feb;36(2):901–42.
Amaral DG, Schumann CM, Nordahl CW. Neuroanatomy of autism. Trends Neurosci. Elsevier; 2008;31(3):137–45.
Pardo CA, Vargas DL, Zimmerman AW. Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry. England; 2005 Dec;17(6):485–95.
Ronald A, Hoekstra RA. Autism spectrum disorders and autistic traits: a decade of new twin studies. Am J Med Genet B Neuropsychiatr Genet. United States; 2011 Apr;156B(3):255–74.
Banerjee S, Riordan M, Bhat MA. Genetic aspects of autism spectrum disorders: insights from animal models. Front Cell Neurosci. Switzerland; 2014;8:58.
Brentani H, Paula CS de, Bordini D, Rolim D, Sato F, Portolese J, et al. Autism spectrum disorders: an overview on diagnosis and treatment. Rev Bras Psiquiatr. Brazil; 2013;35 Suppl 1:S62–72.
Akins RS, Angkustsiri K, Hansen RL. Complementary and alternative medicine in autism: an evidence-based approach to negotiating safe and efficacious interventions with families. Neurotherapeutics. United States; 2010 Jul;7(3):307–19.
Lerner AB, Case JD, Takahashi Y, Lee TH, Mori W. Isolation of melatonin, the pineal gland factor that lightens melanocyteS1. J Am Chem Soc. ACS Publications; 1958;80(10):2587.
Malenka RC, Nestler EJ, Hyman SE, Sydor A, Brown RY. Molecular Neuropharmacology: A Foundation for Clinical Neuroscience. New York: McGrawHill Medical. Book; 2009.
Reiter RJ. The melatonin rhythm: both a clock and a calendar. Experientia. Springer; 1993;49(8):654–64.
Dubocovich ML, Rivera-Bermudez MA, Gerdin MJ, Masana MI. Molecular pharmacology, regulation and function of mammalian melatonin receptors. Front Biosci. United States; 2003 Sep;8:d1093–108
Carocci A, Catalano A, Sinicropi MS. Melatonergic drugs in development. Clin Pharmacol Adv Appl. Dove Press; 2014;6:127.
De Leersnyder H, Zisapel N, Laudon M. Prolonged-release melatonin for children with neurodevelopmental disorders. Pediatr Neurol. Elsevier; 2011;45(1):23–6.
Illnait-Ferrer J. Melatonina: actualidad de una hormona olvidada Melatonin: the actuality of a forgotten hormone. Rev CENIC Ciencias Biológicas. 2012;43(3).
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. Elsevier; 1996;17(1):1–12.
Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Wiley Online Library; 2008.
Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ Br Med J. BMJ Group; 2003;327(7414):557.
Cortesi F, Giannotti F, Sebastiani T, Panunzi S, Valente D. Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: a randomized placebo-controlled trial. J Sleep Res. England; 2012
Garstang J, Wallis M. Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems. Child Care Health Dev. England; 2006 Sep;32(5):585–9.
Wright B, Sims D, Smart S, Alwazeer A, Alderson-Day B, Allgar V, et al. Melatonin versus placebo in children with autism spectrum conditions and severe sleep problems not amenable to behaviour management strategies: a randomised controlled crossover trial. J Autism Dev Disord. United States; 2011 Feb;41(2):175–84.
Levy SE, Mandell DS, Merhar S, Ittenbach RF, Pinto-Martin JA. Use of complementary and alternative medicine among children recently diagnosed with autistic spectrum disorder. J Dev Behav Pediatr. LWW; 2003;24(6):418–23.
Jan JE, Hamilton D, Seward N, Fast DK, Freeman RD, Laudon M. Clinical trials of controlledrelease melatonin in children with sleep-wake cycle disorders. J Pineal Res. New York: Liss, c1984-; 2000;29(1):34–9.
República de Colombia Ministerio de Salud y Protección Social Instituto Nacional de Vigilancia de Medicamentos y Alimentos – INVIMA. RESOLUCIÓN No. 2015013919 DE 13 de Abril de 2015 Por la cual se concede un Registro Sanitario [Internet]. Bogotá: INVIMA; 2015 p. 1–3. Available from: http://web.sivicos.gov.co/registros/pdf/1287670_2015013919.pdf
Neurim Pharmaceuticals. Circadin® 2mg (prolonged-release melatonin) is now commercially available in Colombia [Internet]. 2015 [cited 2016 Oct 16]. Available from: http://www.neurim.com/news/2015-10-01/circadin-2mg-prolonged-release-melatonin-is-nowcommercially-available-in-colombia/
Johnson KP, Malow BA. Assessment and pharmacologic treatment of sleep disturbance in autism. Child Adolesc Psychiatr Clin N Am. Elsevier; 2008;17(4):773–85.
Melke J, Botros HG, Chaste P, Betancur C, Nygren G, Anckarsäter H, et al. Abnormal melatonin synthesis in autism spectrum disorders. Mol Psychiatry. Nature Publishing Group; 2008;13(1):90–8.
Reiter R, Tang L, Garcia JJ, Munoz-Hoyos A. Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci. ENGLAND; 1997;60(25):2255–71.
Chauhan A, Chauhan V. Oxidative stress in autism. Pathophysiology. Elsevier; 2006;13(3):171– 81.
Cohly HHP, Panja A. Immunological findings in autism. Int Rev Neurobiol. Elsevier; 2005;71:317–4
El-Sherif Y, Tesoriero J, Hogan M V, Wieraszko A. Melatonin regulates neuronal plasticity in the hippocampus. J Neurosci Res. United States; 2003 May;72(4):454–60.
Golombek DA, Pevet P, Cardinali DP. Melatonin effects on behavior: possible mediation by the central GABAergic system. Neurosci Biobehav Rev. UNITED STATES; 1996;20(3):403–12.
Niles LP, Pickering DS, Arciszewski MA. Effects of chronic melatonin administration on GABA and diazepam binding in rat brain. J Neural Transm. AUSTRIA; 1987;70(1-2):117–24.
Pandi-Perumal SR, Srinivasan V, Maestroni GJM, Cardinali DP, Poeggeler B, Hardeland R. Melatonin: Nature’s most versatile biological signal? FEBS J. England; 2006 Jul;273(13):2813– 38.
Campino C, Valenzuela FJ, Torres-Farfan C, Reynolds HE, Abarzua-Catalan L, Arteaga E, et al. Melatonin exerts direct inhibitory actions on ACTH responses in the human adrenal gland. Horm Metab Res = Horm und Stoffwechselforsch = Horm Metab. Germany; 2011 May;43(5):337–42.
Malow B, Adkins KW, McGrew SG, Wang L, Goldman SE, Fawkes D, et al. Melatonin for sleep in children with autism: a controlled trial examining dose, tolerability, and outcomes. J Autism Dev Disord. United States; 2012 Aug;42(8):1729–37; author reply 1738.
Jan JE, O’Donnell ME. Use of melatonin in the treatment of paediatric sleep disorders. J Pineal Res. Wiley Online Library; 1996;21(4):193–9
Andersen IM, Kaczmarska J, McGrew SG, Malow BA. Melatonin for insomnia in children with autism spectrum disorders. J Child Neurol. Canada; 2008 May;23(5):482–5.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
INTRODUCCIÓN: El 80% de los niños y adolescentes con trastornos del espectro autista (TEA) presenta algún trastorno del sueño, en cuya génesis al parecer intervienen alteraciones en la regulación de la melatonina. El objetivo de este metaanáli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9037b62234f346e315f429adc4e78177
Autor:
Manuel Castro Samur, Harold Herrera, Daniel Guerrero Bracho, Jairo M. González Díaz, Beatriz H. Caamaño
Publikováno v:
Revista Colombiana de Psiquiatría. 41:672-679
Resumen Introduccion Las estatinas son los medicamentos mas recetados en el mundo, por el beneficio y la seguridad que ofrecen. Sin embargo, pueden causar reacciones adversas a escala neurologica, gastrointestinal, renal y muscular. Objetivo Es descr
Publikováno v:
Revista Colombiana De Psiquiatria
Resumen Introduccion A partir de multiples estudios ejecutados alrededor del planeta, se ha concluido la existencia de un efecto estacional en los nacimientos de los pacientes que luego desarrollan esquizofrenia. Por ello se ha propuesto una relacion
Autor:
Frances Adiukwu, Leila Kamalzadeh, Mariana Pinto da Costa, Ramdas Ransing, Renato de Filippis, Victor Pereira-Sanchez, Amine Larnaout, Jairo M. Gonzalez-Diaz, Mario Eid, Zulvia Syarif, Laura Orsolini, Rodrigo Ramalho, Ramyadarshni Vadivel, Mohammadreza Shalbafan
Publikováno v:
Annals of General Psychiatry, Vol 21, Iss 1, Pp 1-4 (2022)
Abstract Grief is the physical or mental suffering experienced after a major loss, usually the death of a loved one. It is a universal experience, but sociocultural factors, such as cultural or ethnic identity and religious beliefs predict and shape
Externí odkaz:
https://doaj.org/article/871ea800e22445b484807a1760d5ac09
Autor:
Rodrigo Ramalho, Vanessa Chappe, Lisette Alvarez, Gianfranco C.A. Argomedo-Ramos, Guillermo Rivera Arroyo, Graciela L. Bonay, Javiera C. Libuy Mena, Miguel A. Cuellar Hoppe, Domenica N. Cevallos-Robalino, Jairo M. Gonzalez-Diaz
Publikováno v:
Cambridge Prisms: Global Mental Health, Vol 10 (2023)
As mental health issues continue to rise in Latin America, the need for research in this field becomes increasingly pressing. This study aimed to explore the perceived barriers and resources for research and publications among psychiatrists and psych
Externí odkaz:
https://doaj.org/article/dc50ad520cdd41edbb60db1b42d0f5bd